New clinical research conducted by the University of Sherbrooke, Canada, published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, has
Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company (Euronext Brussels: BCART), today announces the market release